Literature DB >> 21603592

Cytotoxic Effect of Arsenic Trioxide in Adenocarcinoma Colorectal Cancer (HT-29) Cells.

Jacqueline J Stevens1, Barbara Graham-Evans, Alice M Walker, Brinda Armstead, Paul B Tchounwou.   

Abstract

Arsenic is a heavy metal that exhibits a high degree of toxicity to various organ systems. In humans, this compound is associated with an increase risk of skin cancer, and may cause cancers of the lung, liver, bladder, kidney, and colon. The mechanism of arsenic-related carcinogenicity remains to be elucidated. Hence, the aim of the present study was to investigate the cytotoxic effects of arsenic trioxide (As(2)O(3)) on adenocarcinoma colorectal cancer (HT-29) cells using the MTT [3-(4,5 dimethylthiazoyl-2-yl)-2,5- diphenyltetrazolium bromide] assay for cell viability. To achieve this objective, HT-29 cells were cultured and exposed to various doses (0, 2, 4, 6, 8, 10, 12, and 14 μg/ml) of arsenic trioxide for 24 h, 48 h, and 72 h respectively, and subsequently assessed for viability following a standard MTT test protocol. Experimental data indicated that arsenic trioxide is cytotoxic to colon cancer cells showing LD(50) values of 9.8, 9.4 and 9.0 μg/ml upon 24, 48 and 72 h of exposure, respectively. There was a dose-dependent response with regard to As(2)O(3) toxicity in HT-29 cells. Although there was a reduction in LD(50) value with increasing exposure time, this decrease was not statistically significant.

Entities:  

Year:  2008        PMID: 21603592      PMCID: PMC3096487     

Source DB:  PubMed          Journal:  Met Ions Biol Med        ISSN: 1257-2535


  16 in total

1.  In-vitro cytotoxic and genotoxic effects of arsenic trioxide on human leukemia (HL-60) cells using the MTT and alkaline single cell gel electrophoresis (Comet) assays.

Authors:  Clement G Yedjou; Paul B Tchounwou
Journal:  Mol Cell Biochem       Date:  2007-01-10       Impact factor: 3.396

2.  Arsenic.

Authors:  H Frumkin; M J Thun
Journal:  CA Cancer J Clin       Date:  2001 Jul-Aug       Impact factor: 508.702

3.  In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.

Authors:  G Q Chen; J Zhu; X G Shi; J H Ni; H J Zhong; G Y Si; X L Jin; W Tang; X S Li; S M Xong; Z X Shen; G L Sun; J Ma; P Zhang; T D Zhang; C Gazin; T Naoe; S J Chen; Z Y Wang; Z Chen
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

4.  Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells.

Authors:  Stephanie K Y Chow; Judy Y W Chan; K P Fung
Journal:  J Cell Biochem       Date:  2004-09-01       Impact factor: 4.429

Review 5.  Arsenic toxicity and potential mechanisms of action.

Authors:  Michael F Hughes
Journal:  Toxicol Lett       Date:  2002-07-07       Impact factor: 4.372

Review 6.  Carcinogenic and systemic health effects associated with arsenic exposure--a critical review.

Authors:  Paul B Tchounwou; Anita K Patlolla; Jose A Centeno
Journal:  Toxicol Pathol       Date:  2003 Nov-Dec       Impact factor: 1.902

7.  Arsenic: health effects, mechanisms of actions, and research issues.

Authors:  C O Abernathy; Y P Liu; D Longfellow; H V Aposhian; B Beck; B Fowler; R Goyer; R Menzer; T Rossman; C Thompson; M Waalkes
Journal:  Environ Health Perspect       Date:  1999-07       Impact factor: 9.031

Review 8.  Biomarkers of exposure: a case study with inorganic arsenic.

Authors:  Michael F Hughes
Journal:  Environ Health Perspect       Date:  2006-11       Impact factor: 9.031

9.  Differential cytotoxic effects of arsenic on human and animal cells.

Authors:  T C Lee; I C Ho
Journal:  Environ Health Perspect       Date:  1994-09       Impact factor: 9.031

10.  Cancer risks associated with arsenic in drinking water.

Authors:  How-Ran Guo
Journal:  Environ Health Perspect       Date:  2007-07       Impact factor: 9.031

View more
  5 in total

1.  Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway.

Authors:  Xiao-Hui Zhang; Ru Feng; Meng Lv; Qian Jiang; Hong-Hu Zhu; Ya-Zhen Qing; Jia-Ling Bao; Xiao-Jun Huang; X Long Zheng
Journal:  Leuk Res       Date:  2013-09-29       Impact factor: 3.156

2.  The effects of arsenic trioxide on DNA synthesis and genotoxicity in human colon cancer cells.

Authors:  Jacqueline J Stevens; Barbara Graham; Alice M Walker; Paul B Tchounwou; Christian Rogers
Journal:  Int J Environ Res Public Health       Date:  2010-04-28       Impact factor: 3.390

3.  Low-dose dose-response for reduced cell viability after exposure of human keratinocyte (HEK001) cells to arsenite.

Authors:  Kenneth T Bogen; Lora L Arnold; Aparajita Chowdhury; Karen L Pennington; Samuel M Cohen
Journal:  Toxicol Rep       Date:  2016-12-14

4.  Construing the Biochemical and Molecular Mechanism Underlying the In Vivo and In Vitro Chemotherapeutic Efficacy of Ruthenium-Baicalein Complex in Colon Cancer.

Authors:  Yixuan Wang; Li Bian; Tania Chakraborty; Torsha Ghosh; Pallakhi Chanda; Souvik Roy
Journal:  Int J Biol Sci       Date:  2019-04-22       Impact factor: 6.580

5.  Arsenic Trioxide Induces Apoptosis via Specific Signaling Pathways in HT-29 Colon Cancer Cells.

Authors:  Jacqueline J Stevens; Barbara Graham; Erika Dugo; Bezawit Berhaneselassie-Sumner; Kenneth Ndebele; Paul B Tchounwou
Journal:  J Cancer Sci Ther       Date:  2016-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.